Ark INNOVATION UCITS ETF (LON:ARCK)
664.30
+13.05 (2.00%)
At close: Jun 17, 2026
35.22% (1Y)
| Assets | 231.07M |
| Expense Ratio | 0.78% |
| PE Ratio | 53.17 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +35.22% |
| Volume | 25,674 |
| Open | 651.90 |
| Previous Close | 651.25 |
| Day's Range | 650.10 - 664.30 |
| 52-Week Low | 488.90 |
| 52-Week High | 715.90 |
| Beta | n/a |
| Holdings | 43 |
| Inception Date | Apr 12, 2024 |
About ARCK
ARXK.DE was created on 2024-04-12 by ARK. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 249.89m in AUM and 45 holdings. This product is actively managed and invests primarily in global equity securities of companies involved in disruptive innovation, defined as the introduction of a technologically enabled new product or service that potentially changes the way the world works.
Asset Class Equity
Category Theme
Stock Exchange London Stock Exchange
Ticker Symbol ARCK
Provider ARK
Performance
ARCK had a total return of 35.22% in the past year, including dividends. Since the fund's inception, the average annual return has been 33.38%.
Top 10 Holdings
50.62% of assets| Name | Symbol | Weight |
|---|---|---|
| Tesla, Inc. | TSLA | 9.18% |
| Robinhood Markets, Inc. | HOOD | 6.32% |
| Advanced Micro Devices, Inc. | AMD | 6.28% |
| CRISPR Therapeutics AG | CRSP | 5.34% |
| Tempus AI, Inc. | TEM | 4.55% |
| Roku, Inc. | ROKU | 4.08% |
| Shopify Inc. | SHOP | 3.95% |
| Beam Therapeutics Inc. | BEAM | 3.84% |
| 10x Genomics, Inc. | TXG | 3.55% |
| Coinbase Global, Inc. | COIN | 3.52% |